Nemera
Nemera, a leading global provider of drug delivery systems, is headquartered in La Verpillière, France, with significant operations across Europe, North America, and Asia. Founded in 2004, the company has established itself in the pharmaceutical and biotechnology industries, focusing on innovative solutions for injectable and inhalation therapies. Nemera's core offerings include advanced devices such as prefilled syringes, auto-injectors, and inhalers, designed to enhance patient experience and medication adherence. Their commitment to quality and user-centric design sets them apart in a competitive market. With a strong emphasis on research and development, Nemera has achieved notable milestones, including partnerships with major pharmaceutical companies and recognition for their cutting-edge technologies. As a trusted partner in drug delivery, Nemera continues to shape the future of healthcare.
DitchCarbon Score
How does Nemera's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nemera's score of 48 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nemera's reported carbon emissions
In 2023, Nemera reported total greenhouse gas emissions of approximately 106.2 million tonnes CO2e. This figure includes 1.3 million tonnes CO2e from Scope 1 emissions, 76,400 tonnes CO2e from Scope 2 emissions, and a significant 104.8 million tonnes CO2e from Scope 3 emissions, which encompass indirect emissions from the supply chain and product lifecycle. Over the past few years, Nemera's emissions have shown fluctuations. In 2022, the company recorded about 117 million tonnes CO2e, with Scope 1 emissions at 1.7 million tonnes CO2e and Scope 2 emissions at 1.1 million tonnes CO2e. The trend indicates a need for robust climate action, which Nemera is addressing through ambitious reduction targets. Nemera has committed to a substantial reduction in greenhouse gas emissions, aiming for a 90% decrease in absolute Scope 1 and Scope 2 emissions by 2030, using 2019 as the baseline year. Additionally, the company plans to reduce Scope 3 emissions from purchased goods and services by 55% per EUR value added within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit warming to 1.5°C. Overall, Nemera's climate commitments reflect a proactive approach to sustainability within the healthcare equipment and supplies sector, demonstrating a clear pathway towards significant emissions reductions in the coming years.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 1,097,050 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 29,972,830 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000 |
| Scope 3 | 121,610,090 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nemera is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
